Clinical Trial Update: SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SU011248 for platinum-refractory urothelial/bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Cancer

Drugs mentioned

• SU011248

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Urothelial Cancer, Bladder Cancer | Phase 2 | Status: COMPLETED